Dr. Daniel Geschwind, MD

NPI: 1730102310
Total Payments
$10,472
2023 Payments
$3,000
Companies
5
Transactions
19

Payment Breakdown by Category

Travel$5,231 (50.0%)
Consulting$4,488 (42.9%)
Food & Beverage$753.41 (7.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $5,231 6 50.0%
Consulting Fee $4,488 2 42.9%
Food and Beverage $753.41 11 7.2%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $4,488 2 $0 (2023)
F. Hoffmann-La Roche AG $3,919 3 $0 (2018)
Takeda Development Center Americas, Inc. $1,754 7 $0 (2017)
MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC. $191.39 3 $0 (2022)
Amgen Inc. $120.04 4 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,000 1 Biogen, Inc. ($3,000)
2022 $1,608 3 Biogen, Inc. ($1,488)
2021 $70.85 1 MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC. ($70.85)
2018 $3,919 3 F. Hoffmann-La Roche AG ($3,919)
2017 $1,874 11 Takeda Development Center Americas, Inc. ($1,754)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/03/2023 Biogen, Inc. Consulting Fee Cash or cash equivalent $3,000.00 General
11/10/2022 MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC. Food and Beverage In-kind items and services $78.54 General
04/03/2022 MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC. Food and Beverage In-kind items and services $42.00 General
03/07/2022 Biogen, Inc. Consulting Fee Cash or cash equivalent $1,487.50 General
12/16/2021 MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC. Food and Beverage In-kind items and services $70.85 General
09/24/2018 F. Hoffmann-La Roche AG Non-Covered Product (Drug) Travel and Lodging In-kind items and services $3,277.86 General
Category: None
09/24/2018 F. Hoffmann-La Roche AG Non-Covered Product (Drug) Travel and Lodging In-kind items and services $413.05 General
Category: None
09/24/2018 F. Hoffmann-La Roche AG Non-Covered Product (Drug) Food and Beverage In-kind items and services $228.27 General
Category: None
11/29/2017 Takeda Development Center Americas, Inc. Travel and Lodging Cash or cash equivalent $1,150.00 General
11/29/2017 Takeda Development Center Americas, Inc. Travel and Lodging Cash or cash equivalent $292.00 General
11/29/2017 Takeda Development Center Americas, Inc. Food and Beverage Cash or cash equivalent $69.46 General
11/29/2017 Takeda Development Center Americas, Inc. Travel and Lodging Cash or cash equivalent $53.58 General
11/29/2017 Takeda Development Center Americas, Inc. Travel and Lodging Cash or cash equivalent $45.00 General
11/28/2017 Takeda Development Center Americas, Inc. Food and Beverage Cash or cash equivalent $94.25 General
11/27/2017 Takeda Development Center Americas, Inc. Food and Beverage Cash or cash equivalent $50.00 General
03/15/2017 Amgen Inc. Food and Beverage In-kind items and services $5.65 General
03/15/2017 Amgen Inc. Food and Beverage In-kind items and services $0.90 General
03/15/2017 Amgen Inc. Food and Beverage In-kind items and services $0.89 General
02/09/2017 Amgen Inc. Food and Beverage In-kind items and services $112.60 General

About Dr. Daniel Geschwind, MD

Dr. Daniel Geschwind, MD is a Neurodevelopmental Disabilities healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730102310.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Geschwind, MD has received a total of $10,472 in payments from pharmaceutical and medical device companies, with $3,000 received in 2023. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($5,231).

Practice Information

  • Specialty Neurodevelopmental Disabilities
  • Other Specialties Neurology
  • Location Los Angeles, CA
  • Active Since 07/25/2006
  • Last Updated 01/16/2020
  • Taxonomy Code 2084P0005X
  • Entity Type Individual
  • NPI Number 1730102310

Products in Payments

  • Non-Covered Product (Drug) $3,919

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurodevelopmental Disabilities Doctors in Los Angeles